benzocaine (EjectDelay)

Dosing and uses of EjectDelay (benzocaine)

• Adult
• Pediatric

 

Adult dosage forms and strengths

gel/topical solution

• 6.3%
• 7.5%
• 10%
• 20%

liquid

• 5%
• 6.3%
• 7.5%
• 10%
• 20%

 

Bee Stings, Minor Burns, Sunburn, Insect Bites

Apply 5-20% to affected area q6-8hr PRN; remove sting prior to application if a bee sting

 

Mouth and Gum Irritation

Apply 10-20% solution (or other topical formulation) PRn

 

Sore Throat/Mouth Pain

1 lozenge dissolved in mouth; repeat q2hr PRN (generally use <2 days)

Apply 1 spray to affected area; spit after 1 min; may repeat up to 4 times

 

Hemorrhoids

Apply 5-20% externally to affected area q4hr

 

Dental pain

Use 2.5-20% solution (or other topical formulation) PRn

 

Boils

Apply 20% to affected area; not to exceed q12hr

 

Premature Ejaculation

EjectDelay (7.5% gel): Apply small amount to the penis gland 15-20 min before sexual intercourse

It can be applied with or without a condom

Washed off after intercourse

 

Pediatric dosage forms and strengths

gel/topical solution

• 6.3%
• 7.5%
• 10%
• 20%

liquid

• 5%
• 6.3%
• 7.5%
• 10%
• 20%

 

Teething Pain

< 4 years

• Safety and efficacy not established

> 4 years

• Apply 7.5-10% (topical/oral) to affected gum area; not to exceed q6hr

 

Bee Stings, Boils, Minor Burns, Sunburn, Insect Bites

< 2 years

• Safety and efficacy not established

> 2 years

• Apply 5-20% to affected area q6-8hr PRN; remove sting prior to application if a bee sting

 

Mouth and Gum Irritation

<2 years: safety and efficacy not established

≥2 years: Apply 10-20% solution (or other topical formulation) PRn

 

Sore Throat/Mouth Pain

<5 years: Safety and efficacy not established

≥5 years

• Oral lozenge: 1 lozenge dissolved in mouth; repeat q2hr PRN (generally use <2 days)
• Oral spray: Apply 1 spray to affected area; spit after 1 min; may repeat up to 4 times

 

Hemorrhoids

<12 years: Safety and efficacy not established

≥12 years: Apply 5-20% externally to affected area q4hr

 

EjectDelay (benzocaine) adverse (side) effects

Frequency not defined

Burning

Contact dermatitis

Edema

Pruritus

Erythema

Rash

Stinging tenderness

Urticaria

Methemoglobenemia

 

Warnings

Contraindications

Hypersensitivity to benzocaine or other ester-type local anesthetics

Secondary bacterial infection of treated area

 

Cautions

Not for prolonged use

Risk of methemoglobinemia when used in mouth or throat

 

Pregnancy and lactation

Pregnancy category: C

Lactation: excretion in milk unknown; use with caution

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.